Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Viacheslav Chubenko"'
Autor:
Alexey Bogdanov, Andrey Bogdanov, Viacheslav Chubenko, Nikita Volkov, Fedor Moiseenko, Vladimir Moiseyenko
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Tumor acidity is one of the cancer hallmarks and is associated with metabolic reprogramming and the use of glycolysis, which results in a high intracellular lactic acid concentration. Cancer cells avoid acid stress major by the activation and express
Externí odkaz:
https://doaj.org/article/397d43979c034621911a5b350c8d6769
Autor:
Viacheslav Chubenko
Publikováno v:
Journal of Modern Oncology. 24:204-208
To this date, the treatment of metastatic colorectal cancer involves continuous drug therapy, the so-called "continuum of care" approach in order to control of tumor growth and try to increase life expectancy for patients. The characteristic is the l
Autor:
Fedor Vladimirovich Moiseenko, Mikhail Fedyanin, Nikita Volkov, Nuriniso Abduloeva, Natalia Levchenko, Viacheslav Chubenko, Albina Zhabina, Mariya Stepanova, Mikhail Kramchaninov, Elizaveta Artemeva, Vladimir Moiseyenko
Publikováno v:
Journal of Clinical Oncology. 40:e21049-e21049
e21049 Background: Local and international recommendations for anticancer treatment are formed and changed based on the results of clinical trials. A feature of most clinical trials is the strict criteria used to select “safe” patients without se
Autor:
M. Yu. Fedyanin, L. A. Zagorskaya, O. L. Fakhrutdinova, O. V. Nekrasova, S. A. Belukhin, A. A. Mishchenko, L. Yu. Vladimirova, Alfia Khasanova, B. Kh. Kertiev, Ye. V. Karabina, A. K. Ivanova, A. V. Belyayeva, Viacheslav Chubenko, A. V. Androsova, Alexey Tryakin, P S Feoktistova, Rashida Orlova, Guzel Mukhametshina, S. N. Osodoyeva, R. R. Malina, I. A. Pokatayev, O. Yu. Novikova, L. V. Khalikova, V. M. Sherstnev, A. A. Meshcheryakov, Sanal Erdniev, Elena Artamonova, Kh. S. Musayeva, Irina L. Popova, L. A. Mukova, Larisa Bolotina, F. V. Moiseyenko, A. I. Katz, Ye. S. Kuzmina, G. I. Kosar, I. Yu. Stradayeva, Vladimir Moiseyenko, S. A. Tyulyandin, A S Zhabina, A. Belonogov
Publikováno v:
Malignant tumours. 9:53-63
Purpose. To assess the incidence and severity of adverse events; to explore clinical factors associated with grade 3–4 non-hematologic toxicity; to assess the immediate efficacy and progression-free survival during treatment with the FOLFIRI regime
Autor:
S V Limareva, Irina V. Evstigneeva, A. E. Storozhakova, E P Prokofyeva, Elena Karabina, L V Manziuk, Irina L. Popova, N Yu Samaneva, Natalya A Abramova, Elena A. Kalabanova, Natalya Mikhailovna Tikhanovskaya, Viacheslav Chubenko, Larisa Bolotina, I. S. Mitashok, L Yu Vladimirova, I I Andreyashkina, Elena Kovalenko, Vera Gorbunova, Guzel Mukhametshina, Alfia Khasanova, Ya. V. Svetitskaya, A A Teterich, E A Gaysina, T A Snezhko
Publikováno v:
Современная онкология, Vol 18, Iss 3, Pp 27-32 (2016)
The article shows the experience of eribulin application in actual clinical practice in Oncology institutions of the Russian Federation concerning metastatic breast cancer. We have analyzed the efficacy of the drug in case of different subtypes of th
Publikováno v:
BMJ Case Rep
Locally advanced gastric cancer (GC) is often managed by neoadjuvant chemotherapy and surgery; however, pathological complete responses to preoperative systemic treatment are rare. Some GCs are characterised by high-level microsatellite instability (
Autor:
Olga Fakhrudinova, Alexandr Belonogov, Elena Karabina, Viacheslav Chubenko, Alfiya Khasanova, Fedor Moiseenko, Viktor Sherstnev, Polina Feoktistova, Guzel Mukhametshina, Irina Stradaeva, Larisa Bolotina, Sergei Tjulandin, Evgeniya Kuzmina, Mikhail Fedyanin, Hedi Musaeva, Andrey Micshenko, Rashida Orlova, Oksana Nekrasova, Liubov Yu Vladimirova, Olga Novikova
Publikováno v:
Journal of Clinical Oncology. 37:e15007-e15007
e15007 Background: Afl is one of the antiagiogenic agents used for the treatment for mCRC. Cardiovascular toxicity of Afl is shown to be a main reason of the drug discontinuation but there are no studies on factors associated with nonhem adverse even
Autor:
Anna Belyaeva, Viacheslav Chubenko, Ludmila Zagorskaya, Iuliia Zaytseva, Elena Bit-sava, Robert V Broyde, Vitaly Egorenkov, Ksenia Shelekhova, Vladimir Moiseyenko
Publikováno v:
Journal of Clinical Oncology. 36:e12664-e12664
e12664Background: The purpose of the breast cancer (BC) preoperative therapy (PT) is to achieve a complete pathological response (pCR) that correlates with overall survival or a decrease in its siz...
Autor:
Vladimir Moiseyenko, Viacheslav Chubenko, Belyaeva Oa, Tatiana Semiglazova, Sofia Vershinina, G. S. Kireeva, A S Zhabina, Aleksandr Stukov, Filatova Lv, Dilorom Latipova, Vladimir G. Bespalov
Publikováno v:
Journal of Clinical Oncology. 33:e22180-e22180
e22180 Background: Gemcitabine is known to exert a therapeutic effect on brain tumors despite the limited permeability of the blood-brain barrier (BBB). Experimental studies to explore the mechanis...
Autor:
Aleksandr Stukov, Belyaeva Oa, Sofia Vershinina, Yaroslav Murazov, Viacheslav Chubenko, Vladimir G. Bespalov, Valentina Lukyanchikova, Tatyana Semiglazova, Fedor Moiseenko
Publikováno v:
Journal of Clinical Oncology. 31:e13005-e13005
e13005 Background: Gemcitabine has a very modest potency to penetrate blood-brain barrier (BBB). So far it's therapeutic activity in intracranial tumors is unknown. Methods: we explored the effect of gemcitabine (G) on overall survival in models of i